These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9581893)

  • 1. Oral SIV, SHIV, and HIV type 1 infection.
    Ruprecht RM; Baba TW; Liska V; Ayehunie S; Andersen J; Montefiori DC; Trichel A; Murphey-Corb M; Martin L; Rizvi TA; Bernacky BJ; Buchl SJ; Keeling M
    AIDS Res Hum Retroviruses; 1998 Apr; 14 Suppl 1():S97-103. PubMed ID: 9581893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral transmission of primate lentiviruses.
    Ruprecht RM; Baba TW; Liska V; Ray NB; Martin LN; Murphey-Corb M; Rizvi TA; Bernacky BJ; Keeling ME; McClure HM; Andersen J
    J Infect Dis; 1999 May; 179 Suppl 3():S408-12. PubMed ID: 10099108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatal immunopathogenesis by SIV/HIV-1 (SHIV) containing a variant form of the HIV-1SF33 env gene in juvenile and newborn rhesus macaques.
    Luciw PA; Mandell CP; Himathongkham S; Li J; Low TA; Schmidt KA; Shaw KE; Cheng-Mayer C
    Virology; 1999 Oct; 263(1):112-27. PubMed ID: 10544087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infected macaques that controlled replication of SIVmac or nonpathogenic SHIV developed sterilizing resistance against pathogenic SHIV(KU-1).
    Stephens EB; Joag SV; Atkinson B; Sahni M; Li Z; Foresman L; Adany I; Narayan O
    Virology; 1997 Aug; 234(2):328-39. PubMed ID: 9268165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SIV/HIV Nef recombinant virus (SHIVnef) produces simian AIDS in rhesus macaques.
    Mandell CP; Reyes RA; Cho K; Sawai ET; Fang AL; Schmidt KA; Luciw PA
    Virology; 1999 Dec; 265(2):235-51. PubMed ID: 10600596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronology of genetic changes in the vpu, env, and Nef genes of chimeric simian-human immunodeficiency virus (strain HXB2) during acquisition of virulence for pig-tailed macaques.
    McCormick-Davis C; Zhao LJ; Mukherjee S; Leung K; Sheffer D; Joag SV; Narayan O; Stephens EB
    Virology; 1998 Sep; 248(2):275-83. PubMed ID: 9721236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly attenuated rabies virus-based vaccine vectors expressing simian-human immunodeficiency virus89.6P Env and simian immunodeficiency virusmac239 Gag are safe in rhesus macaques and protect from an AIDS-like disease.
    McKenna PM; Koser ML; Carlson KR; Montefiori DC; Letvin NL; Papaneri AB; Pomerantz RJ; Dietzschold B; Silvera P; McGettigan JP; Schnell MJ
    J Infect Dis; 2007 Apr; 195(7):980-8. PubMed ID: 17330788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal transmission of pathogenic CXCR4-utilizing SHIVSF33A variants in rhesus macaques.
    Harouse JM; Tan RC; Gettie A; Dailey P; Marx PA; Luciw PA; Cheng-Mayer C
    Virology; 1998 Aug; 248(1):95-107. PubMed ID: 9705259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Derivation and biological characterization of a molecular clone of SHIV(KU-2) that causes AIDS, neurological disease, and renal disease in rhesus macaques.
    Liu ZQ; Muhkerjee S; Sahni M; McCormick-Davis C; Leung K; Li Z; Gattone VH; Tian C; Doms RW; Hoffman TL; Raghavan R; Narayan O; Stephens EB
    Virology; 1999 Aug; 260(2):295-307. PubMed ID: 10417264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate differences between simian-human immunodeficiency virus (SHIV)(KU-2)-infected rhesus and pig-tailed macaques in development of neurological disease.
    Buch SJ; Villinger F; Pinson D; Hou Y; Adany I; Li Z; Dalal R; Raghavan R; Kumar A; Narayan O
    Virology; 2002 Mar; 295(1):54-62. PubMed ID: 12033765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection.
    Baba TW; Liska V; Hofmann-Lehmann R; Vlasak J; Xu W; Ayehunie S; Cavacini LA; Posner MR; Katinger H; Stiegler G; Bernacky BJ; Rizvi TA; Schmidt R; Hill LR; Keeling ME; Lu Y; Wright JE; Chou TC; Ruprecht RM
    Nat Med; 2000 Feb; 6(2):200-6. PubMed ID: 10655110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
    Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
    J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral burden and disease progression in rhesus monkeys infected with chimeric simian-human immunodeficiency viruses.
    Reimann KA; Watson A; Dailey PJ; Lin W; Lord CI; Steenbeke TD; Parker RA; Axthelm MK; Karlsson GB
    Virology; 1999 Mar; 256(1):15-21. PubMed ID: 10087222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of HIV-specific antibody response and protection against vaginal SHIV transmission by intranasal immunization with inactivated SHIV-capturing nanospheres in macaques.
    Miyake A; Akagi T; Enose Y; Ueno M; Kawamura M; Horiuchi R; Hiraishi K; Adachi M; Serizawa T; Narayan O; Akashi M; Baba M; Hayami M
    J Med Virol; 2004 Jul; 73(3):368-77. PubMed ID: 15170630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macaques infected with live attenuated SIVmac are protected against superinfection via the rectal mucosa.
    Cranage MP; Whatmore AM; Sharpe SA; Cook N; Polyanskaya N; Leech S; Smith JD; Rud EW; Dennis MJ; Hall GA
    Virology; 1997 Mar; 229(1):143-54. PubMed ID: 9123856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fusion of the upstream vpu sequences to the env of simian human immunodeficiency virus (SHIV(KU-1bMC33)) results in the synthesis of two envelope precursor proteins, increased numbers of virus particles associated with the cell surface and is pathogenic for pig-tailed macaques.
    Hout DR; Gomez ML; Pacyniak E; Mulcahy ER; Gomez LM; Jackson M; Flick M; Fegley B; McCormick C; Wisdom BJ; Culley N; Pinson DM; Powers M; Wong SW; Stephens EB
    Virology; 2004 May; 323(1):91-107. PubMed ID: 15165822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of genital transmission of SIV: a hypothesis based on transmission studies and the location of SIV in the genital tract of chronically infected female rhesus macaques.
    Miller CJ; Alexander NJ; Vogel P; Anderson J; Marx PA
    J Med Primatol; 1992; 21(2-3):64-8. PubMed ID: 1433268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virus replication and disease progression inversely correlate with SIV tat evolution in morphine-dependent and SIV/SHIV-infected Indian rhesus macaques.
    Noel RJ; Kumar A
    Virology; 2006 Mar; 346(1):127-38. PubMed ID: 16313937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell-tropic simian immunodeficiency virus (SIV) and simian-human immunodeficiency viruses are readily transmitted by vaginal inoculation of rhesus macaques, and Langerhans' cells of the female genital tract are infected with SIV.
    Miller CJ; Hu J
    J Infect Dis; 1999 May; 179 Suppl 3(Suppl 3):S413-7. PubMed ID: 10099109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques.
    Blaschke S; Hannig H; Buske C; Kaup FJ; Hunsmann G; Bodemer W
    J Med Virol; 2001 Sep; 65(1):114-20. PubMed ID: 11505452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.